The activation of NF-κB signaling by IL1β/IL1R1 leads to the upregulation of HNF4α, establishing a feedback loop that sustains NF-κB pathway activation and propels inflammation towards cancer development [327]. The gene discussed is NFKB1; the disease is cancer.